Trey and Finny discuss a structured approach to investment, emphasizing the importance of avoiding problematic sectors while seeking companies that create value for stakeholders. They highlight the challenge of identifying true excellence among numerous biotech firms and the necessity of a comprehensive understanding of the market to uncover substantial value. Their "business 360" approach ensures a holistic view of potential investments, focusing on the interplay between various stakeholders.
